Venture-Backed Startups
128,270 companies with verified investor relationships.
Ceibo operates mining dust control solutions through its subsidiary Casia, which applies dust suppressors to reduce emissions while saving water and improving operational safety in mining operations.
2 investors
CEIM (Centre d'entreprises et d'innovation de Montréal) is a technology incubator and accelerator that provides advisory services to innovative startups in areas such as financing, market validation, commercialization, and international business development. Based in Old Montreal, Quebec, it supports companies across digital technologies, life sciences, creative industries, cleantech, and 4.0 manufacturing.
1 investor
AI-powered talent acquisition automation platform providing recruiting and workforce management software
2 investors
0 investors
0 investors
Cekura provides testing, monitoring, and optimization tools for voice and chat AI agents. The platform enables developers to simulate scenarios, run evaluations before production, replay real conversations, and continuously improve agents through voice observability and analytics.
2 investors
CEL-SCI is a biotechnology company developing cancer immunotherapy products, including its lead candidate Multikine for head and neck cancer, which showed a survival benefit in a Phase III trial. It also develops the early-stage LEAPS platform for rheumatoid arthritis and other autoimmune and infectious diseases.
0 investors
Celadyne develops a domestically manufactured multi-layer proton exchange membrane that reduces hydrogen crossover to improve durability and efficiency in fuel cells and electrolyzers. Its membrane targets defense and industrial electrochemical systems, with roadmap applications including flow batteries, electrochemical separation, and compression for markets such as trucking, shipping, steel, and grid power.
1 investor
Celaid Therapeutics develops hematopoietic stem cell expansion technology, including a method to replace albumin with polyvinyl alcohol and to expand human hematopoietic stem cells ex vivo in large quantities. The company applies this technology to stem cell transplantation and gene therapy for blood cancers such as leukemia and other blood and genetic diseases.
2 investors
0 investors
Celcuity is a commercial-stage biotechnology company developing targeted cancer therapies for tumors involving the PAM (PI3K/AKT/mTOR) pathway, including breast, prostate, lung, endometrial, colon, and ovarian cancers. Its lead candidate, gedatolisib, targets all Class I PI3K isoforms and the mTORC1 and mTORC2 complexes and is being evaluated across multiple oncology clinical programs.
2 investors
Celcy develops a smart, automatic kitchen oven that cooks meals autonomously, with connected features aimed at consumers seeking convenient home meal preparation. The product is positioned as a next-generation kitchen appliance for at-home cooking.
2 investors
Celea is a biopharmaceutical company developing next-generation therapies for serious respiratory diseases, with a lead antifibrotic drug candidate, deupirfenidone, in Phase 3 development for idiopathic pulmonary fibrosis (IPF). The oral therapy is a modified version of FDA-approved pirfenidone and is being tested in a head-to-head superiority trial against an existing antifibrotic treatment.
1 investor
Celebal Technologies is a global data and AI solutions provider serving enterprise clients across manufacturing, retail, oil and gas, energy, BFSI, healthcare, media, and public sectors. The company offers data engineering, generative AI, machine learning, data science, cloud integration, and app modernization services.
1 investor
0 investors
0 investors
0 investors
0 investors
Celebrus provides a first-party behavioral data capture and real-time identity resolution platform that builds customer profiles from web, mobile, kiosk, server, and offline interactions without tags or pixels. It serves marketing personalization, fraud detection, and digital analytics teams, feeding enriched, privacy-compliant profiles into existing martech and fraud tech stacks.
1 investor
0 investors
CeleCor Therapeutics is developing zalunfiban, an investigational next-generation GPIIb/IIIa platelet inhibitor injected subcutaneously for the pre-hospital treatment of STEMI heart attacks at the first point of medical contact. The company focuses on improving acute myocardial infarction treatment.
0 investors
3 investors
Celer is a blockchain interoperability protocol that enables decentralized applications to access tokens, DeFi products, NFTs, and governance across multiple blockchains through a simplified user experience. The platform serves developers building cross-chain applications and end-users of dApps seeking multi-chain asset access.
8 investors
Celera (Acelérame) is a Spanish talent accelerator that identifies, develops, and connects young high-potential individuals through its own leadership-development program and methodology. It serves individuals and partner organizations, focusing on developing future leaders in Spain.
1 investor